Literature DB >> 19487370

Three considerations before advising 5-alpha-reductase inhibitors for chemoprevention.

Patrick C Walsh.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19487370     DOI： 10.1200/JCO.2009.22.9070

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Evolving role of 5-alpha reductase inhibitors in chemoprevention.

Authors:  Wesley M White; Edward D Kim
Journal:  Nat Rev Clin Oncol       Date:  2010-09       Impact factor: 66.675

Review 2.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 3.  The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression.

Authors:  Abdulmaged M Traish; Ashwini Mulgaonkar; Nicholas Giordano
Journal:  Korean J Urol       Date:  2014-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.